4. July 2018

New Kilo Lab

Extension of service: ISO 9001 quality regulated synthesis for your supply chain. We have asked our most experienced chemists to design a multi-purpose synthesis kilo lab with the possibility to perform a plethora of complex syntheses. The new mini-plant supports our efforts regarding the regular supply of fine and specialty…
24. May 2018

Meet us at Chemspec, Cologne, June 20-21

ChiroBlock will be exhibiting at Chemspec Europe 2018, the 33rd International Exhibition for Fine and Speciality Chemicals. If you are interested in a meeting, please do not hesitate to contact us. We are sharing a big booth (E78, Hall 8) with our partners from a local chemistry partnering network. This…
13. March 2018

ERDF supported Investment

ChiroBlock was granted a financial support by the European Regional Development Fund to facilitate the investment plans of our company. As part of ChiroBlock’s strategy, we decided to built a new “multi purpose pilot plant” facility. Currently, our activities in developing and synthesizing new fine and specialty chemicals are limited…
10. January 2018

Meet us at 2nd European Chemistry Partnering

Meet us at Europe’s leading Chemistry industry Partnering event. It is all about innovation, cooperation, investments and customers. Agenda of the 2nd European Chemistry Partnering event: The establishment of mutual business contacts is the focus of European Chemistry Partnering. The course of the event is simple. On-site registration begins on…
30. November 2017

ChiroBlock: Grant of the CIR Certificate

ChiroBlock successfully applied for being recognized as R&D partner eligible for the French Research Tax Credit Scheme. Last month we were granted the so called “CIR Certificate” from the French Ministery of Research and Innovation. It is an acknowledgement of ChiroBlock’s long-standing and permanent activities in chemical research and development.…
25. May 2017

The Importance of Further Training and Education for Employees

Businesses today must do everything possible to stay competitive and maintain a highly qualified and motivated staff. Training presents a prime opportunity to expand the knowledge base of all employees. One of the most important reasons to offer further training and education to employees is to ensure that work skills…
5. March 2017

Marriage of Chemistry to Plant-Based Economy

The finite nature of fossil resources has been discussed for decades as well as their negative impact on our environment. The number and decisiveness of real consequences of these facts are not too impressive by now. Single, locally restricted and mainly half-hearted measures have been taken such as the ban…
1. November 2016

Nurturing chemical start-ups

Starting-up a business is not an easy task. Founding a chemical company, certainly, belongs to the more complex business ventures. The consequences are obvious: In contrast to vibrant founding activities in the IT and trading businesses, new chemical companies are scarce. Given the importance of the chemical industry in Germany…
26. July 2016

New focus: Natural Compounds

ChiroBlock has been dealing with syntheses of (chiral) building blocks, many of them constituents of natural compounds, for more than a decade. However, directly addressing entire, complex natural compounds has not been the business focus so far. In July this started to change. A new technical department was equipped, staffed…
16. April 2016

Promising News at Lipocalyx

Lipocalyx, a German biotech company in the field of non-viral transfection reagents, has been developing in a very impressive way since its foundation about five years ago. Four different product lines were established all of which show excellent transfecting properties. Their superiority compared to competing products did not only result…
26. January 2016

Sparking the Love for Chemistry

Chemistry naturally is fascinating. It doesn’t take much to enthuse people for this unparalleled mix of science, art and industrial applications – just one spark. However, this ignition doesn’t com from books. Chemistry needs to be touched, made, experienced, observed. For safety reasons, this can’t be done in a garage…
23. July 2015

Lab Space Extended

As a response to the increasing demand for ChiroBlock’s services, we extended our lab space by additional 100 sqm. The new laboratory has been designed for re-synthesis projects of customer specific compounds derived from either our MoleculeFactory – or our ReDesignFactory – business branch on scales between 100 g and…
15. March 2015

Ten Years Vocational Training at ChiroBlock: Best Apprentice Just Graduated

Qualified and dedicated staff is the most valuable treasure of every company. Just hiring people from outside is only second choice. While scientists have to study at universities and need to gain additional know-how and experiences at other institutions, technical staff is best qualified together with their future employer. ChiroBlock…
26. January 2015

R&D Milestones Reached

At the beginning of January, two major milestones of one of our internal R&D projects were reached. In our search for new preserving agents we both succeeded in identifying three new, more active compounds and, on the other hand, we could prove their low toxicity in vitro. Both aspects are…
17. November 2014

New QC lab opened

While Quality Control always has been an important issue at ChiroBlock, the relevance of this department has got a substantial push in the process of further developing our quality management system. Especially the requirements of our “ReDesignFactory”-business as well as the very first examples of providing special compounds as starting…
1. September 2014

ISO 9001 Certification

Responding both to the rising number of customer requirements and to the need of increasing our internal efficiency, ChiroBlock successfully applied for the certification of its quality management system according to the ISO 9001 norm. The two days audit, carried out by the CERTURIA agency and witnessed by the DAKKS…
5. August 2014

New Publication on the Cytotoxicity of ChiroBlock’s beta-Nitro Carboxylates

Beta-Nitro carboxylic esters are not only valuable precursors for (enantio pure) amino acid derivatives as ChiroBlock revealed in its “IP-Factory” business field some years ago, but they also proved to exhibit remarkable physiological properties. A research group headed by Prof. Dr. R. Csuk of the University of Halle investigated the…
26. June 2014

The Foundation for German Science awards ChiroBlock with seal of approval

The “Stifterverband für die deutsche Wissenschaft” has honoured ChiroBlock with the seal of approval for its Research & Development. “The Stifterverband tends to the bases of innovation: strong universities, promoting young talent, and ensuring fruitful exchange between business and science. That significantly boosts the competitiveness of German businesses.” says Kurt…
10. April 2014

News from our IPFactory: Lipocalyx starts international distribution for its Viromer technology

Halle, Mar 27th, 2014: Lipocalyx, a company offering the novel Viromer® transfection reagents, today announces the start of its sales in Taiwan, France and China. The company has entered into distribution agreements with GenDiscovery from Taiwan, the French firm Interchim and also with Maibio out of Shanghai, China. Steffen Panzner,…
10. October 2013

New R&D project started!

A new internal R&D project was launched on October the 1st. Together with the reseach group of Dr. Reichl at the Technical University in Braunschweig, ChiroBlock is aiming at new preserving agents. There is both an increasing demand for new types of such agents as well as for better synthetic…
26. August 2013

Achievements in Health – Safety and Environment – The new HSE Report

One central issue in ChiroBlock’s HSE policy is the responsible use of (electrical) energy. Despite the fact that the conversion of matter requires much energy in most cases, the German chemical industry strives to reduce the energy consumption in order to decrease the environmental footprint of its products and…
13. July 2013

Report: 2nd quarter 2013

ChiroBlock successfully completed the first major projects in the business field “ReDesign Factory” in 2013. Here, new, validated synthesis processes on lab scale have been developed which replaced older, less efficient ones. One customer, for example, benefits from an improved hydrogenation procedure resulting in a substantial reduction of the…
26. May 2013

3rd 4chiral workshop – Free Download

Free Download: Presentations given by Prof. Dr. René Csuk (Professor for Organic Chemistry, MLU), Dr. Jens Holz (Group Leader, Leibniz Institute for Catalysis) and Dr. Sergey Sergeyev (COO, The European Center for Chirality), as well as Dr. Uwe Müller (CEO, HAPILA GmbH) The 3rd 4chiral workshop was held last…
26. January 2013

Meet us at the 3rd 4chiral workshop on 26th of March in Bitterfeld

ChiroBlock is an established partner and co-founder of the 4chiral network. 4chiral is a network with superior expertise in R&D and production of chiral compounds. With its motto OUR CORE COMPETENCE IS CHIRALITY this network is conducting research and development projects in the field of chiral compounds, whereby the main…
26. October 2012

Synthesis of chiral b2-amino acids by asymmetric hydrogenation

Chiral b2-amino acids can be synthesized using their prochiral precursors b-aryl- or b-heteroaryl-a-N- benzyl/N-acetyl/N-Boc substituted a-aminomethylacrylates. These substrates were obtained using a Baylis-Hillman reaction, followed by acylation and amination. A broad scope of chiral catalysts, especially commercially available phosphorus ligands in combination with the transition-metal rhodium, have been tested…
2. August 2012

New approaches to 2-substituted 3-amino alcohols and related derivatives

Another in-house research project on enantioselective catalysis was successfully finished last month. Our researchers managed to find new approaches to 2-substituted 3-amino alcohols and related derivatives. These findings complement ChiroBlock’s proprietary know-how on enantioselective Michael additions in an ideal way and lay the basis for new business opportunities in our…
2. February 2012

BioTech Start up Lipocalyx – ChiroBlock have finished an other important milestone

Only half a year after the foundation of the biotech company Lipocalyx, an important milestone of the demanding business plan could be reached successfully: The first proof of a new and promising drug delivery approach was delivered. ChiroBlock, which took a strategical share in Lipocalyx, supports the company in providing…
14. July 2011

New Distribution Partner

Last month, a contract between the Germany based trading company ABCR, one of the leading providers of research chemicals, and ChiroBlock was signed. This agreement grants ABCR an exclusive and world wide right to sell research quantities of a selection of ChiroBlock’s compounds resulting from own research projects. This new…
15. January 2011

Continuous Flow Syntheses – ChiroBlock implements micro reactor system

After a longer period of testing several continuous flow system architectures, ChiroBlock has completed the implementation of the most suitable micro reactor system as standard synthesis operation this month. This investment is a response to the increasing demand for developing safe and high yielding synthetic processes for potentially hazardous and/or…
2. June 2010

Research Co-Laboration on Catalysis

This month, a research & development co-operation project between ChiroBlock and the Leibniz Institute of Catalysis (LIKAT) in Rostock was initiated. New approaches to small chiral building blocks are being investigated together during the next two years. While ChiroBlock contributes its experiences on chiral C-C couplings, the well renowned Rostock…
19. April 2010

New Patent Filed

As a result from ChiroBlock’s continuous research on stereo selective catalysis, another patent was filed recently (DE102009055183). There, our latest discoveries on catalysed formations of C-C – bonds are disclosed. This know-how forms the basis for new approaches to new, valuable – enantiomerically pure – building blocks.
7. July 2003

Management System Revised

ssl encoded chemical formula input tool In response to the requirements of our contract research customers in the life science industries, our management approaches have been thoroughly restructured and optimized. Now, there are four general areas of internal, project focused management structures ensuring efficient processes of rendering services. The new…
10. January 2002

New in-house research project started

beta amino acid Customers of ChiroBlock appreciate its focus on chemical research and small scale syntheses. So they only pay for what they need. Hidden cross – subsidies, as common in highly diversified ‘one-stop-shops’, are avoided. But customers also retain esteem for ChiroBlock’s staff as our experienced chemists are permanently…
7. October 2001

Start-up of the year 2001

ChiroBlock award ChiroBlock was awarded the title “Start-up of the year 2001 in Saxony – Anhalt” by a jury of senior managers, journalists and politicians. The positive development during the first two years, the clear business strategy and the focus on innovative solutions in chemistry were named as main criteria…
23. April 2001

New location

Chemistry Innovation Center Bitterfeld-Wolfen Two years after its foundation, ChiroBlock has moved from Merseburg to Wolfen. Our new location, the ‘Chemistry Innovation Center Bitterfeld-Wolfen’, offers much better conditions for our further development. New, modern laboratories, an excellent infrastructure, skilled chemical manpower and close collaborations between the numerous local chemical companies…
7. February 2001

New patent pending

A new patent covering the enantioselective chemo catalytic Michael addition of organo zinc reagents to 3-nitro acrylic acid esters has been filed by ChiroBlock (No. 10107528). It is the result of our extensive in-house research on this reaction type and should path the way for further success in this field…

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. OK! data policy.